title: Regulation of beta 1- and beta 2-adrenoceptors following chronic treatment with beta-adrenoceptor antagonists.
abstract: The effect of chronic pretreatment of guinea pigs with various beta-adrenoceptor antagonists on the binding characteristics of the radioligand 125I-cyanopindolol (ICYP) and responsiveness of adenylate cyclase to isoprenaline in the gastrocnemius muscle (beta 2-adrenoceptors) and the left ventricle (beta 1-adrenoceptors) were compared. Pretreatment of guinea pigs with propranolol or ICI 118,551 for one week significantly increased the density of the beta 2-adrenoceptors in the gastrocnemius muscle. Atenolol pretreatment for one week did not affect the density of the receptors. Pretreatment of the animals with pindolol for one week reduced the density of beta 2-adrenoceptors in skeletal muscle. In the left ventricle pretreatment of the guinea pigs with any of the antagonists did not alter either the density or the KD of beta 1-adrenoceptors. The responsiveness of adenylate cyclase to isoprenaline (10(-4) M) in the left ventricle or skeletal muscle was not affected when the guinea pigs were pretreated with propranolol. Pretreatment of the guinea pigs with reserpine (0.5 mg.kg-1) intraperitoneally for one week, to deplete catecholamines did not affect beta-adrenoceptor density or KD in the left ventricle or skeletal muscle. We conclude that the regulation of beta-adrenoceptors by the antagonist may not be caused by the prevention of the access of endogenous agonists to beta-adrenoceptors and it is dependent on the selectivity of the antagonist and on the susceptibility of the receptors to regulation.
authors.affiliation: University Department of Materia Medica, Stobhill General Hospital, Glasgow, Scotland.
authors.forename: M S
authors.initials: MS
authors.lastname: Elfellah
authors.forename: J L
authors.initials: JL
authors.lastname: Reid
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D020120:Iodocyanopindolol; D007700:Kinetics; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D010869:Pindolol / Q000031:analogs & derivatives; D011943:Receptors, Adrenergic, beta / Q000187:drug effects
chemical_list: D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D020120:Iodocyanopindolol; D010869:Pindolol; D000262:Adenylyl Cyclases